Burjeel Holdings Achieves Record Q3’25 Revenue With 27.5% Net Profit Growth

Burjeel Holdings PLC reported a record revenue of AED1,422 million for Q3’25, marking a 7.9% increase. This growth highlights the company's strong market position and operational resilience. The rise in revenue is attributed to increased patient visits and a diverse case mix, with significant contributions from high-value specialties.

The Group's revenue for the first nine months of 2025 reached AED4,099 million, a 10.6% increase. Patient visits rose by 7.3% to 5.1 million, indicating an expanding market share and deeper community engagement. This growth outpaces regional population trends, showcasing Burjeel's increasing influence.

In Q3’25, EBITDA grew by 17.1% to AED320 million, with margins improving to 22.5% from 20.7% in Q3’24. This was driven by a higher proportion of complex medical services and effective cost management across maturing assets. Consequently, EBITDA for the first nine months of 2025 rose by 15.3% to AED807 million, with margins increasing to 19.7% from 18.9% in the same period last year.

The Hospitals segment accounted for 88% of total Group revenue, growing by 4.6% to AED1,247 million in Q3’25 and by 8.3% to AED3,618 million in the first nine months of 2025. This growth was driven by increased patient numbers and a robust case mix at facilities like Burjeel Medical City and Medeor Hospitals in Abu Dhabi and Dubai.

EBITDA for the Hospitals segment rose by 20.1% in Q3’25 and by 14.0% in the first nine months of the year, with margins reaching 25.8% in Q3’25 and 23.7% over nine months due to efficiency improvements across inventory and workforce management.

Burjeel Medical City Achievements

Burjeel Medical City (BMC), a key hub for complex services, saw its revenue grow by 10.9% to AED975 million in the first nine months of 2025, with a Q3’25 increase of 7.1%. BMC's performance was bolstered by higher outpatient numbers and rising oncology volumes, leading to a 19.4% increase in patient volumes during this period.

BMC's EBITDA surged by 46.8% in Q3’25, achieving a record margin of 22%. For the first nine months of the year, EBITDA increased by 29.8%, with margins expanding to 18.9%, driven by scale efficiencies and disciplined cost control.

Medical Centres Expansion

The Medical Centres segment maintained strong momentum with revenue rising by 15.8% to AED111 million in Q3’25 and by 22.9% to AED340 million over nine months due to more than forty new medical centres opening across the UAE and Saudi Arabia.

"The third quarter marked a record performance for Burjeel Holdings," said John Sunil, CEO of Burjeel Holdings."Strategic investments have made the Group one of the region’s most resilient healthcare ecosystems."

Net profit for Q3’25 reached AED175 million, up by 27.5%, with net margins improving from 10.4% to 12.3%. For the first nine months of the year, net profit increased by 18.2%, reaching AED362 million with an enhanced net margin of 8.8%, reflecting sustained earnings momentum.

With inputs from WAM